Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.07.03.186411
Publication URI: http://dx.doi.org/10.1101/2020.07.03.186411
Type: Preprint